COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 191 filers reported holding COHERUS BIOSCIENCES INC in Q2 2020. The put-call ratio across all filers is 1.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,762,734 | -11.0% | 2,342,977 | +1.6% | 0.28% | -4.4% |
| Q2 2023 | $9,846,797 | -36.1% | 2,306,041 | +2.3% | 0.30% | -37.9% |
| Q1 2023 | $15,418,060 | -6.7% | 2,254,102 | +8.0% | 0.48% | -8.4% |
| Q4 2022 | $16,525,665 | -19.7% | 2,086,574 | -2.6% | 0.52% | -25.1% |
| Q3 2022 | $20,579,000 | +22.4% | 2,141,380 | -7.8% | 0.70% | +38.6% |
| Q2 2022 | $16,812,000 | -40.6% | 2,322,168 | +5.9% | 0.50% | -29.8% |
| Q1 2022 | $28,306,000 | -15.0% | 2,192,602 | +5.1% | 0.72% | -8.5% |
| Q4 2021 | $33,312,000 | -3.8% | 2,087,187 | -3.2% | 0.78% | -3.9% |
| Q3 2021 | $34,634,000 | +25.8% | 2,155,221 | +8.3% | 0.81% | +29.0% |
| Q2 2021 | $27,528,000 | -10.3% | 1,990,443 | -5.3% | 0.63% | -7.8% |
| Q1 2021 | $30,706,000 | -0.9% | 2,101,687 | +17.9% | 0.68% | -6.9% |
| Q4 2020 | $30,990,000 | +80.3% | 1,783,080 | +90.2% | 0.73% | +47.4% |
| Q3 2020 | $17,190,000 | +56.5% | 937,274 | +52.4% | 0.50% | +49.1% |
| Q2 2020 | $10,984,000 | – | 615,032 | – | 0.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 1,077,839 | $17,483,000 | 5.86% |
| Rubric Capital Management LP | 1,583,061 | $25,677,000 | 4.06% |
| Sofinnova Investments, Inc. | 1,933,221 | $31,357,000 | 2.90% |
| Consonance Capital Management LP | 2,020,002 | $32,764,000 | 2.44% |
| Rock Springs Capital Management LP | 1,950,000 | $31,629,000 | 1.31% |
| Hound Partners | 665,444 | $10,794,000 | 1.01% |
| Temasek Holdings (Private) Ltd | 7,381,116 | $119,722,000 | 0.88% |
| Avidity Partners Management LP | 382,000 | $6,196,000 | 0.86% |
| TANG CAPITAL MANAGEMENT LLC | 350,000 | $5,677,000 | 0.80% |
| KNOTT DAVID M | 67,039 | $1,087,000 | 0.69% |